Photo by impulsq from unsplash
Multiple myeloma (MM) is a complex disease characterized by considerable genetic heterogeneity. The updated NCCN Guidelines for MM have added new "preferred" regimens for transplant and nontransplant candidates, and have… Click to show full abstract
Multiple myeloma (MM) is a complex disease characterized by considerable genetic heterogeneity. The updated NCCN Guidelines for MM have added new "preferred" regimens for transplant and nontransplant candidates, and have moved some formerly "preferred" regimens to the "other" category. Supportive care has improved outcomes for patients, and new treatments in combination have extended survival for patients with MM. Novel agents on the horizon are poised to raise the bar even further.
Keywords:
options management;
treatment options;
multiple myeloma;
management multiple;
new treatment
Journal Title: Journal of the National Comprehensive Cancer Network : JNCCN
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the National Comprehensive Cancer Network : JNCCN
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!